日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Identification of sequence polymorphism in the D-loop region of mitochondrial DNA as a risk factor for breast cancer

线粒体DNA D-loop区序列多态性的鉴定是乳腺癌的风险因素

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.16353
Nie, Qian; Zhang, Wenzhe; Lin, Songping; Huang, Meng; Li, Yan; Qiu, Yibin; Li, Jing; Chen, Xiaobin; Wang, Yali; Tong, Xin; Wu, Jinqiao; He, Peng; Cai, Qindong; Chen, Lili; Chen, Minyan; Guo, Wenhui; Lin, Yuxiang; Yu, Liuwen; Hou, Jialin; Cai, Weifeng; Chen, Hanxi; Wang, Chuan; Fu, Fangmeng
肿瘤
线粒体
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients

白细胞线粒体DNA拷贝数高是乳腺癌患者预后不良的因素之一。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-10838-x
Zhang, Wenzhe; Lin, Songping; Zeng, Bangwei; Chen, Xiaobin; Chen, Lili; Chen, Minyan; Guo, Wenhui; Lin, Yuxiang; Yu, Liuwen; Hou, Jialin; Li, Yan; Li, Shengmei; Jin, Xuan; Cai, Weifeng; Zhang, Kun; Nie, Qian; Chen, Hanxi; Li, Jing; He, Peng; Cai, Qindong; Qiu, Yibin; Wang, Chuan; Fu, Fangmeng
肿瘤
肿瘤免疫
乳腺癌
线粒体
细胞生物学
发表日期：2023
文献求助 收藏

Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy

辅助激素治疗时机与激素受体阳性、人表皮生长因子受体2阴性、未接受化疗的早期乳腺癌患者总生存期的关系

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2021.45934
Fu, Fangmeng; Yu, Liuwen; Zeng, Bangwei; Chen, Minyan; Guo, Wenhui; Chen, Lili; Lin, Yuxiang; Hou, Jialin; Li, Jing; Li, Yan; Li, Shengmei; Chen, Xiaobin; Zhang, Wenzhe; Jin, Xuan; Cai, Weifeng; Zhang, Kun; Chen, Hanxi; Qiu, Yibin; Nie, Qian; Wang, Chuan; Jacobs, Lisa
肿瘤
肿瘤免疫
信号转导
乳腺癌
Human
免疫/内分泌
发表日期：2022
文献求助 收藏

Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients.

人工神经网络（ANN）模型在预测中国双侧原发性乳腺癌患者BRCA1/2种系有害变异中的临床应用

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-10160-y
Li Yan, Chen Lili, Lv Jinxing, Chen Xiaobin, Zeng Bangwei, Chen Minyan, Guo Wenhui, Lin Yuxiang, Yu Liuwen, Hou Jialin, Li Jing, Zhou Peng, Zhang Wenzhe, Li Shengmei, Jin Xuan, Cai Weifeng, Zhang Kun, Huang Yeyuan, Wang Chuan, Fu Fangmeng
神经科学
肿瘤免疫
发表日期：2022
文献求助 收藏

Dual HER2 Blockade versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

HER2阳性早期乳腺癌曲妥珠单抗联合方案中双重HER2阻断与单药治疗的比较：随机对照试验的系统评价和荟萃分析

期刊:Journal of Oncology
影响因子:
doi:10.1155/2020/5169278
Yu, Liuwen; Fu, Fangmeng; Li, Jing; Huang, Meng; Zeng, Bangwei; Lin, Yuxiang; Mei, Qian; Lv, Jinxing; Wang, Chuan
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏